Atlas Trials

Establishment of an ex Vivo Tumor Collection of Triple-negative Breast Cancers in Order to Validate the Interest of Innovative Therapies and the Search for Predictive Biomarkers of Response to Treatment

Clinical trial NCT05404321 · RECRUITING

Trial details

NCT number
NCT05404321
Sponsor
Centre Francois Baclesse
Status
RECRUITING
Study type
OBSERVATIONAL
Triple Negative Breast CancerOrganoid
Start date
2023-01-09
Primary completion
2028-06-01
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.